Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00419627
Verified January 2007 by Hillel Yaffe Medical Center. Recruitment status was: Not yet recruiting
The purpose of this study is to evaluate the presence of proteins in solid tumors which may lead to an immune response
Condition or disease
Colorectal NeoplasmsStomach NeoplasmsPancreatic NeoplasmsBreast NeoplasmsOvarian Cancer
The main objective of the study is to evaluate which proteins are presented by the HLA complex of solid tumors. Secondary objectives include to evaluate whether an immune response specific to these proteins has actually been provoked and whether there is a similar immune response following recurrence. Real specimens will be evaluated using PCR and mass spectrometry.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
Child, Adult, Senior
Sexes Eligible for Study:
Patients with adenocarcinoma of breast, colon, rectum, ovary , stomach, pancreas
Withdrawal of consent
Small specimen which does not allow to retrieve tissue without interfering with pathologic evaluation